GE: Optison™

OPTISON™, is based on sterile non-pyrogenic suspension of microspheres of human serum albumin, to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border

Company Web Site:Optison

Latest safety warning regarding the use of Optison™.

 

Ultrasound Contrast Agents
Approved	In Development
Bracco: SonoVue®	Acusphere, Inc™: magify™
Bristol-Myers Squibb: DEFINITY®	AION Diagnostics, Inc: modified porous silicon
GE: OPTISON™	Targeson, LLC: Targestar™
IMACOR: Imagent	ImaRx Therapeutics, Inc: SonoLysis™
	POINT Biomedical: CARDIOsphere™

 

 

 

Please Note:

The trademarks, copyrights, company, product , & organization names shown on this site are provided for reference purposes. Each is owned by the respective companies & organizations. Unless stated otherwise, none are affiliated with EchoChief.com or its publisher, Insonoart, Inc.

The web sites of Insonoart, Inc are not intended to provide medical advice, nor is any information here a substitute for professional healthcare. Consult your doctor or other healthcare provider for information about your diagnosis, treatment or condition.